AU JESSIE L-S has a total of 16 patent applications. Its first patent ever was published in 2000. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are STREMMEL WOLFGANG, AHMAD IMRAN and HENDERSON MORLEY PLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | Canada | 2 | |
#4 | Australia | 1 | |
#5 | China | 1 | |
#6 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Peptides | |
#5 | Enzymes | |
#6 | Analysing materials | |
#7 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Au Jessie L-S | 16 |
#2 | Wientjes M Guillaume | 13 |
#3 | Wientjes Guillaume | 3 |
#4 | Wang Jie | 2 |
#5 | Lu Ze | 2 |
Publication | Filing date | Title |
---|---|---|
US2012225115A1 | Methods and compositions for improved deliver, expression or activity of RNA interference agents | |
US6995145B1 | Methods and compositions for modulating drug activity through telomere damage | |
WO0074667A2 | Compositions active in telomere damage comprising a taxane and telomerase inhibitor | |
US7217735B1 | Methods and compositions for enhancing delivery of therapeutic agents to tissues |